Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Tobacco Induced Diseases
Published in: Tobacco Induced Diseases 1/2014

Open Access 01-06-2014 | Meeting abstract

Smoking cessation prior to elective plastic surgery: why, when and how?

Authors: Vasileios Theocharidis, Konstantinos P Economopoulos

Published in: Tobacco Induced Diseases | Special Issue 1/2014

Login to get access

Excerpt

Tobacco is a serious nuisance in plastic surgery, mainly through the effects of its inhaled constituents on wound healing physiology. While there are thousands of chemical compounds in the inhaled smoke, the most prominent ones are nicotine, carbon monoxide and hydrogen cyanide, which are partially responsible for impaired wound healing through decreased oxygen delivery and utilization, and deranged collagen deposition [1]. Our aim is to summarize the existing literature on the effects of smoking in various plastic surgical procedures, and on the correct timing and available methods of preoperative smoking cessation. …
Literature
1.
2.
Rees TD, Liverett DM, Guy CL: The Effect of Cigarette Smoking on Skin-Flap Survival in the Face Lift Patient. Plastic and Reconstructive Surgery. 1984, 73 (6): 911-915. 10.1097/00006534-198406000-00009.CrossRefPubMed
3.
Manassa EH, Hertl CH, Olbrisch RR: Wound Healing Problems in Smokers and Nonsmokers after 132 Abdominoplasties. Plastic and Reconstructive Surgery. 2003, 111 (6): 2082-2087. 10.1097/01.PRS.0000057144.62727.C8.CrossRefPubMed
4.
Bikhchandani J, Varma SK, Henderson HP: Is it justified to refuse breast reduction to smokers? Journal of plastic, reconstructive & aesthetic surgery. JPRAS. 2007, 60 (9): 1050-1054.PubMed
5.
McCarthy CM, Mehrara BJ, Riedel E, Davidge K, Hinson A, Disa JJ, Cordeiro PG, Pusic AL: Predicting complications following expander/implant breast reconstruction: an outcomes analysis based on preoperative clinical risk. Plast Reconstr Surg. 2008, 121 (6): 1886-92. 10.1097/PRS.0b013e31817151c4.CrossRefPubMed
6.
Chang DW, Reece GP, Wang B, Robb GL, Miller MJ, Evans GR, Langstein HN, Kroll SS: Effect of smoking on complications in patients undergoing free TRAM flap breast reconstruction. Plast Reconstr Surg. 2000, 105 (7): 2374-80. 10.1097/00006534-200006000-00010.CrossRefPubMed
7.
Chang LD, Buncke G, Slezak S, Buncke HJ: Cigarette smoking, plastic surgery, and microsurgery. J Reconstr Microsurg. 1996, 12 (7): 467-74. 10.1055/s-2007-1006620.CrossRefPubMed
8.
Van Adrichem LN, Hovius SE, van Strik R, van der Meulen JC: The acute effect of cigarette smoking on the microcirculation of a replanted digit. J Hand Surg Am. 1992, 17 (2): 230-4. 10.1016/0363-5023(92)90397-8.CrossRefPubMed
9.
Dec W: A meta-analysis of success rates for digit replantation. Tech Hand Up Extrem Surg. 2006, 10 (3): 124-9. 10.1097/01.bth.0000225005.64605.17.CrossRefPubMed
10.
Payne CE, Southern SJ: Urinary point-of-care test for smoking in the pre-operative assessment of patients undergoing elective plastic surgery. J Plast Reconstr Aesthet Surg. 2006, 59 (11): 1156-61. 10.1016/j.bjps.2005.12.053.CrossRefPubMed
11.
Rinker B: The evils of nicotine: an evidence-based guide to smoking and plastic surgery. Ann Plast Surg. 2013, 70 (5): 599-605. 10.1097/SAP.0b013e3182764fcd.CrossRefPubMed
12.
Mahvan T, Namdar R, Voorhees K, Smith PC, Ackerman W: Clinical Inquiry: which smoking cessation interventions work best?. J Fam Pract. 2011, 60 (7): 430-1.PubMed
Metadata
Title
Smoking cessation prior to elective plastic surgery: why, when and how?
Authors
Vasileios Theocharidis
Konstantinos P Economopoulos
Publication date
01-06-2014
Publisher
BioMed Central
Published in
Tobacco Induced Diseases / Issue Special Issue 1/2014
Electronic ISSN: 1617-9625
DOI
https://doi.org/10.1186/1617-9625-12-S1-A18

Other articles of this Special Issue 1/2014

Tobacco Induced Diseases 1/2014 Go to the issue

Meeting abstract

Novel curriculum of smoking cessation for dental students

Meeting abstract

Nicotinic augmentation of anti-inflammatory GSK3b signaling

Meeting abstract

Smoking cessation changes basic metabolism, body weight, leptin and insulin levels, adipose tissue percentage, index of insulin resistance and index of insulin secretion

Meeting abstract

Intervention program to modify the smoking habit in employee group of Athens' social welfare organization using motivational interviewing techniques and Trans theoretical Model of Behavior Change

Meeting abstract

Analysis of acceptance of the smoking ban in Greece

Meeting abstract

Randomized controlled trial of the Tobacco Tactics website versus 1-800-QUIT-NOW telephone line among Operating Engineers

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits